Search Results

FDA-approved treatment for Demodex blepharitis shortens treatment, improves quality of life.

Subjects: DEMODEX; BLEPHARITIS; QUALITY of lifeUNITED States. Food & Drug Administration

• Source: Managed Healthcare Executive. Jul2024, Vol. 34 Issue 7, p34-35. 2p.

Record details

Effects of game-based digital therapeutics on attention deficit hyperactivity disorder in children and adolescents as assessed by parents or teachers: a systematic review and meta-analysis.

• Authors : Oh, SuA; Choi, Jina; Han, Doug Hyun

Subjects: TREATMENT of attention-deficit hyperactivity disorder; ONLINE information services; PSYCHOLOGY information storage & retrieval systems

• Source: European Child & Adolescent Psychiatry. Feb2024, Vol. 33 Issue 2, p481-493. 13p.

Record details

How Controversy and Socioeconomic Factors Influence Stem Cell Research.

• Authors : Casey, Daniel P.; McCartney, Grace M.; Doroski, Derek M.

Subjects: CLINICAL trials; MULTIPLE regression analysis; SOCIOECONOMIC factors

• Source: Issues in Law & Medicine. Fall2023, Vol. 38 Issue 2, p147-165. 19p.

Record details

Psychometrics of patient-reported bother from side effects of treatment single-items in industry-sponsored oncology trials.

• Authors : Trask, Peter C. (AUTHOR); Holt, Tracy (AUTHOR); Pearman, Timothy (AUTHOR)

Subjects: UNITED States. Food & Drug Administration; PSYCHOMETRICS; ONCOLOGY

• Source: Quality of Life Research. Sep2023, Vol. 32 Issue 9, p2601-2615. 15p. 7 Charts, 2 Graphs.

Record details

International Society for Quality of Life Research commentary on the US Food and Drug Administration draft guidance for industry on core patient-reported outcomes in cancer clinical trials.

• Authors : Brady, Keri J. S. (AUTHOR); Peipert, John Devin (AUTHOR); Atkinson, Thomas M. (AUTHOR)

Subjects: UNITED States. Food & Drug Administration; PATIENT reported outcome measures; CLINICAL trials

• Source: Quality of Life Research. Aug2023, Vol. 32 Issue 8, p2155-2163. 9p.

Record details

A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial.

• Authors : Kane, John M. (AUTHOR); Eshet, Roy (AUTHOR); Harary, Eran (AUTHOR)

Subjects: UNITED States. Food & Drug Administration; OLANZAPINE; PEOPLE with schizophreniaUNITED States

• Source: CNS Drugs. Aug2024, Vol. 38 Issue 8, p625-636. 12p.

Record details

Pediatric Device Clinical Trials Activity: 1999-2022.

• Authors : Dienstman, Joshua; Stachelek, Stanley J.; Krieger, Abba M.

Subjects: T-test (Statistics); RESEARCH funding; CLINICAL trials

• Source: Pediatrics. Aug2024, Vol. 154 Issue 2, p1-9. 9p.

Record details

Vaccines: hope vs reality.

• Authors : Lawton, Graham

Subjects: VACCINES; COVID-19; COVID-19 pandemic

• Source: New Scientist. 11/21/2020, Vol. 248 Issue 3309, p8-11. 4p.

Record details

More research needed regarding psychedelics' effects on youths.

• Authors : Enos, Gary

Subjects: CLINICAL trials; HALLUCINOGENIC drugs; UNITED States. Food & Drug Administration

• Source: Alcoholism & Drug Abuse Weekly. 5/13/2024, Vol. 36 Issue 19, p1-8. 8p.

Record details

Discontinuation and nonpublication of clinical trials for the pharmacologic treatment of posttraumatic stress disorder among military veterans.

• Authors : Weygandt, Jonas (AUTHOR); Moody, Morgan (AUTHOR); Sajjadi, Nicholas B. (AUTHOR)

Subjects: UNITED States. Food & Drug Administration; POST-traumatic stress disorder; VETERANS

• Source: Journal of Traumatic Stress. Apr2023, Vol. 36 Issue 2, p325-332. 8p. 3 Charts.

Record details